Stroke Prevention and the In-House Model

Size: px
Start display at page:

Download "Stroke Prevention and the In-House Model"

Transcription

1 1 PRE-DISCHARGE PLAN FOR SECONDARY STROKE IN PATIENTS WITH STROKE OR TRANSIENT ISCHEMIC ATTACK By Renee HultzBrown A Masters Project Submitted to the Faculty of the COLLEGE OF NURSING In Partial Fulfillment of the Requirements for the Degree of MASTER OF SCIENCE In the Graduate College THE UNIVERSITY OF ARIZONA

2 2 STATEMENT BY AUTHOR This masters project has been submitted in partial fulfillment of requirements for an advanced degree at The University of Arizona and is deposited in the University Library to be made available to borrowers under rules of the Library. Brief quotations from this masters project are allowable without special permission, provided that accurate acknowledgment of source is made. Requests for permission for extended quotation from or reproduction of this manuscript in whole or in part may be granted by the head of the major department or the Dean of the Graduate College when in his or her judgment the proposed use of the material is in the interests of scholarship. In all other instances, however, permission must be obtained from the author. SIGNED: Renee M. HultzBrown APPROVAL BY MASTER S PROJECT DIRECTOR This Master s Project has been approved on the date shown below: Leslie Ritter, PhD, RN May 9, 2008

3 3 ACKNOWLEDGEMENTS I would like to acknowledge my husband, who has supported me through the last three years. Thank you Jonathan, you have been a friend and a quiet listener. Thanks to both my daughters for understanding that I had a goal that lasted a long time and seemed to never end. Love and thanks to my Mom for being here with me over the last month while I wrote this project and holding down the fort. And finally, but not least in any way, thank you to Dr. Leslie Ritter and Dr. Donna Velasquez for making this project an absolute learning experience for me and for continual encouragement.

4 4 DEDICATION This project is dedicated to Nancy Ann Brown who was an educator and supported my pursuing higher education. She would have loved to see me graduate with this degree.

5 5 TABLE OF CONTENTS LIST OF ILLUSTRATIONS 6 LIST OF TABLES...7 ABSTRACT...8 CHAPTER ONE PURPOSE ANDSIGNIFICANCE...9 Introduction..9 Problem Statement..11 Purpose of Project...12 Significance to Nursing Definition of Terms. 13 Theoretical Framework...15 Summary...18 CHAPTER TWO REVIEW OF THE LITERATURE...21 Introduction.21 Structure Process Determining Risk Factors for Stroke.. 24 Guidelines for Prevention of Secondary Stroke..25 Outcome Summary. 33 CHAPTER THREE PROJECT IN DETAIL..34 Introduction.34 Procedures...34 Results.36 Steps in Implementation Plan..42 CHAPTER FOUR DISCUSSION AND CONCLUSION.44 REFERENCES...48

6 6 ILLUSTRATIONS Figure 1-1 Theoretical Framework Describing Secondary Stroke Prevention...20 Figure 3-1 Patient Population Demographics.39 Figure 3-2 Patient Discharge Treatments on 30 Inpatients 41

7 7 LIST OF TABLES Table 2-1 GWTG Stroke Quality Measures 32

8 8 ABSTRACT While it is known that the use of practice guidelines for patients with acute stroke or transient ischemic attack (TIA) results in improved health outcomes, few hospitals systematically use these guidelines. Donabedian s quality improvement model was used to describe an urban southwest hospital system of care for stroke, measure standard benchmarks for the assessment of second stroke, and develop an education plan for prevention of second stroke and TIA. Results indicate that, while the hospital does not systematically use stroke guidelines for the assessment of risk for second stroke, all of the necessary system elements to implement the guidelines are available. The pre-discharge implementation plan provides guideline-driven information that could potentially decrease the incidence of second stroke.

9 9 CHAPTER ONE PURPOSE AND SIGNIFICANCE Introduction Each year the United States spends an estimated $43 billion on the care of stroke patients. Direct medical costs are estimated at $28 billion and the indirect costs from lack of productivity and other factors are approximately $15 million per year (American Heart Association [AHA], 2006). Stroke is also the leading cause of adult disability. Most stroke patients are left without a vocational way of earning an income, a third need help with activities of daily living, and a quarter are unable to ambulate without assistance (Tuhrim, 2003). Of the 700,000 yearly stroke victims; 200,000 are recurrent stroke patients (AHA, 2006). Eighty-five percent of all strokes are transient ischemic attacks (TIA) or major ischemic strokes. Fifteen percent are hemorrhagic strokes (Tuhrim, 2003). This project addresses only major ischemic stroke or TIA. A second stroke can be either a second TIA or ischemic stroke (Sacco, et al, 2006). The highest incidence for a second stroke is within the first seven days after an ischemic event, a TIA or mini-stroke (Sacco, et al., 2006). TIA is currently defined as a brief focal neurological deficit in the brain or retina that lasts less than 24 hours without evidence of infarct. The prevalence for cerebral infarct after TIA is 11% at the ages of 55 to 64, 22% between the ages of 65 to 69, 28% at the ages of 70 to 74 years, 32% between 75 to 79 years and 40% at ages 80 to 85 years (Rosamund, et al., 2007). TIA s are the precursor in 15% of all strokes and if unrecognized, can represent the greatest morbidity and mortality for stroke patients in the first thirty-ninety days after their first TIA (Lovett, et al, 2003). Fifty-percent of patients

10 10 who experience a TIA fail to notify their healthcare provider. Approximately one-third of TIA s would reveal as a true ischemic event by diffusion-weighted magnetic resonance imaging. Within the first year of having their first TIA, 25% of patients will die (Rosamund, et al., 2007). While TIA itself has short term effects, the significance is that this can herald a major stroke, which is why it requires timely and aggressive treatment to prevent death and disability. Studies have demonstrated that in-hospital programs that utilize standard guidelines for the prevention of a second stroke can improve outcomes by reducing risk factors for second stroke (LaBresh, et al., 2007; LaBresh, et al., 2008). A quality assurance system that analyzes performance parameters and uses the analysis for improving care is a necessary component for in-hospital secondary stroke prevention programs (Schwamm, et al., 2005). For example, using medical chart review and primary care physician surveys, one study showed that although 95% of primary care physicians intended to treat elevated cholesterol in their patients, fewer than 18% actually reach low density lipid cholesterol (LDL-C) treatment goals (LaBresh & Tyler, 2005). It is known that lowering high levels of LDL-C reduces stroke risk significantly. Systematic changes to improve guideline adherence are necessary to improve outcomes by healthcare professionals (Sacco, et al., 2006). It has been shown that stroke and transient ischemic attack (TIA) patients alike decrease their secondary stroke risk considerably by learning about their own cardiovascular health maintenance, risk assessment and lifestyle behaviors (Greenlund,

11 11 et al., 2002). Despite the fact that the assessment of risk for secondary stroke patients is recommended by hospital accreditation and national agencies, there remains a gap across the country regarding how hospital patients learn about their second stroke risks (Roe & Durham, 2004; Sacco, et al, 2006). Some of this gap is related to a fragmentation of evidenced-based stroke care. The current guidelines from the American Heart (AHA) and American Stroke Associations (ASA) include a risk assessment of each patient to determine their educational, pharmacological and rehabilitation maintenance needs. Effective coordination and collaboration among experienced multidisciplinary health professionals is paramount to provide an integrative, multifactorial approach to secondary stroke prevention (Schwamm, et al., 2005). Problem Statement While it is known that the use of in-hospital standard guidelines will reduce second stroke, the implementation of these guidelines remains underutilized. A need persists for collaborative multidisciplinary team use of standard guidelines for prevention of second stroke. Identifying risk factors, initiating treatment plans and patient education for TIA or stroke patients before discharge from the hospital can significantly reduce risk for second stroke. (LaBresh, et al., 2004).

12 12 Purpose of Project The aims of this project are to: 1) Describe the system of care for stroke, in an urban, Tucson, Arizona hospital. 2) Describe the hospital s data from the Get with the Guidelines (GWTG SM ) Stroke Patient Management Tool, for the prevention of second stroke. The Joint Commission (JC) has developed a skill set and disease specific care based on the American Heart Association (AHA) and American Stroke Association (ASA) national guidelines for the care of acute stroke patients for Primary Stroke Center certification for hospitals. The GWTG SM Stroke Patient Management Tool gathers a data set for hospitalized stroke patients. This quality assessment tool for stroke and TIA inpatients, gathers performance data measuring adherence to AHA/ASA guidelines. Performance measures pertinent for this project are the use of antithrombotics in-hospital, diabetic and hypertension medication at discharge, lipid management upon discharge, addressing modifications for lifestyle based on a body mass index (BMI) score [greater than or equal to 25kg/m 2 ] and smoking cessation counseling on discharge. 3) Develop a hospital plan for implementing in-hospital stroke guidelines for prevention of second stroke for patients with TIA or stroke.

13 13 Significance to Nursing The advanced nurse practitioner is in a unique role for the assessment and integration of a comprehensive stroke care model. Advanced practice nursing is built upon a complete approach to patient care through thorough history taking, physical assessment and complex disease management. It is known when providers of healthcare, including nurse practitioners, take the time to educate patients about health, diet and exercise, lifestyle behaviors of patients can improve (Greenlund, et al., 2002). There is evidence that patient s are more apt to continue recommendations about their health care and medications when the education occurs in the hospital setting. This is a window of opportunity for the nurse practitioner when the risks become real to patients and their families (LaBresh & Tyler, 2005). The in-patient setting offers a setting for the nurse practitioner (NP) to counsel the patient about their risks that could extend to primary care for follow up on secondary stroke prevention (Alberts, et al, 2005). Nurse practitioner evaluation of secondary stroke risk and subsequent patient education can empower patients by providing a goal-oriented, treatment plan when they leave the hospital. Nurse practitioner evaluation of secondary stroke risk and subsequent follow up can lead to research which will provide evidence of improved patient outcomes after stroke. Definition of Terms Primary Prevention: refers to the management of established disease processes and cardiovascular disease risk factors that could lead to a patient s first stroke. This includes

14 14 pertinent history taking, monitoring and treatment of blood pressure, serum glucose, cholesterol, body weight, exercise, healthy diet and smoking cessation (Schwamm, et al., 2005). First Stroke: First TIA or major ischemic stroke. Secondary Prevention: Refers to the initiation of stricter management of primary interventions once diagnosed with a stroke or TIA along with tighter treatment of underlying disease. This includes the use of appropriate hypertensive medications, a lipid lowering agent, and use of an antiplatelet adhesion/ anticoagulant agents. (Halkes, et al., 2006). Second Stroke: Second TIA or major ischemic stroke. Get With The Guidelines (GWTG SM ): is the premier hospital-based quality improvement program for the American Heart Association and the American Stroke Association. It empowers healthcare provider teams to consistently treat heart and stroke patients according to the most up-to-date guidelines. (AHA, 2008). Stroke Center Certification: A hospital certification designated by the Joint Commission meeting criteria for quality of care in stroke treatment based on recommendations from the Brain Attack Coalition and the American Stroke Association for comprehensive stroke center requirements (Alberts, et al., 2005). Hospitals are evaluated and receive a certification designation based on an assessment of: 1) Compliance with consensus-based national standards, 2) Effective use of primary stroke center recommendations and

15 15 clinical practice guidelines to manage and optimize care and 3) Performance measurement and improvement activities (Joint Commission, 2004). Risk reduction (RR): a term used to describe the overall benefit of modification of stroke risk reduction which is this plan for implementation goal. Advanced Practice Nurse (APN) or Nurse Practitioner (NP): must be defined due to its ambiguous nature in the hospital setting (Gardner, Chang & Duffield, 2007). Role definition is important to impart in this model because it is not only a case management, leadership role. The APN practitioner provides a direct clinical service to stroke patients with focused care that is evidenced based (Gardner, Chang & Duffield, 2007). The use of guidelines for their practice is implemented along with the multidisciplinary team to carry out the clinical stroke pathway of care (Alberts, et al, 2005). The APN practitioner will use a professional practice model that includes a complete history and physical, review of labs, tests, determining cardiovascular system risk assessment, including the source of stroke and associated secondary stroke risks. Theoretical Framework The theoretical framework for this project is Donabedian s model which is based on the principles of health care quality assurance. Avedis Donabedian developed a theoretical framework in the 1980 s emphasizing a dynamic process of improvement cycles that look at system structure, process intervention of care and the outcome effects. Donabedian s model posits three main components: 1) structure quality, 2) process quality and 3) outcome quality (Chin & Muramatsu, 2003). Structure is the

16 16 organizational design of how a health system runs. Structure relates to how the culture of health professionals are utilized within a health care setting, the characteristics of the providers, resources, tools, staffing ratios, ect. (Chin & Muramatsu, 2003). For Aim 1 of this study, an evaluation of hospital structure will be to identify stroke multidisciplinary team members, identify stroke protocols for assessment of secondary stroke risk and administrative support that is currently in place at the time of this study. For Aim 2 of this study, the process of care is the set of activities that occur between patients and their providers that is being measured. This will be an analysis of AHA/ASA s Get with the Guidelines (GWTG SM ) for Stroke Patient Management Tool via the internet which measures the national guidelines for secondary stroke care. Data will be obtained on measured benchmarks of care that follow the guidelines and descriptive data on a patient population. Donabedian has described similarities in his model and a quality improvement model; in practice these two models are combined as a dynamic process (Donabedian, 1992). Quality or process outcome is improved in cycles by analyzing an improvement intervention in patient care, studying the effect of that care and finally using that data to repeat the cycle (Chin & Muramatsu, 2003). Process outcomes are a logical assumption by nature; however they are dependent upon the functional use of the measure and whether or not its use is an adequate indicator. Measures show clinician s accountability to set standards of care, improvement of care performance and informative information to consumers (Chin & Muramatsu, 2003).

17 17 Finally, the third part of this model is outcome quality: the change in the patient s health status or as a result of care provided (Donabedian, 2003). In this project, the model is used to evaluate the information obtained from Aim 1 and 2 to develop an implementation plan for collaboration of secondary stroke care provided in this hospital setting for stroke patients prior to discharge that could improve patient outcomes. Rhee, Donabedian & Burney (1987) used a hospital emergency room structure to exemplify the workings of this framework. The structure level and scope of concern is important in determining the appropriate elements that are to be assessed. In example, all collaborative health professionals who are providing health care to an individual within a unit structure are part of the quality assessment (Rhee, Donabedian, & Burney, 1987). The quality assessment itself can be any given strategy of care with a given impact on health that may be observed from three different levels of service: 1) the healthcare relationship provided or the amenities of care, 2) the greatest improvement in health of the individual within the limitations of the patient s capacity to improve, or 3) the value of the strategy of care that was provided that is presumed to provide the most benefit (Rhee, Donabedian & Burney, 1987). There are favorable attributes that were defined by the authors that focus on features we still deem pertinent to what quality assessment should focus upon. These features, now more commonly called benchmarks or standards of care include: timeliness of care, the appropriateness, reliability and validity of diagnostic and therapeutic interventions, clinician skill in executing care decisions, maintenance of continuity of care for referral or next level of care, accuracy in

18 18 documentation, patient education, motivation and prevention (Rhee, Donabedian & Burney, 1987). Donabedian (2003) describes a quality monitoring cycle that includes: 1) obtaining performance data, 2) pattern analysis of data, 3) interpretation of this data that might provide a hypothesis of the pattern observed, 4) taking preventative, corrective, promotive action based on the causative hypothesis and 5) obtain subsequent performance data to determine the conclusion of the action taken (Donabedian, 2003). A proportionate representative sampling of cases, either gathered by simple or random technique primarily related to a diagnosis is one way that is described as the most frequently used for assessment (Donabedian, 1988). The measurement of the quality is based on set standards of care or criteria that are scientifically evidenced based. While national health standards of quality for specific disease categories are used, many times individual cases are best measured based on the limited short term goals of care that have been shown to be clinically effective (Chin & Muramatsu, 2003). Quality action or adjustments, for example, could be education, procedure, training or tools that improve on the desired outcome (Donabedian, 2003). Summary Donabedian s theoretical framework is applicable for this project, as described in Figure 1-1. The framework describes a quality assurance process with which the author utilizes to examine the acute stroke care in a 309 bed, urban community hospital. The data obtained pertains to a small unidentifiable, convenience sample with acute ischemic

19 19 stroke or TIA and the evidenced based care they received. Accordingly, the first aim of this project will be to describe the stroke structure of care within the hospital, and then secondly, the process of care will be to analyze GWTG s Patient Management Tool data performance measures for secondary stroke care. And finally, the third aim of this project will be to make an implementation plan of second stroke risk for inpatients prior to discharge.

20 20 Structure Hospital s Medical, ICU and Telemetry Units Hospitalist /Physicians, Specialists, Nurse Managers, Nurses Policy for stroke team assessment of secondary stroke risk Identify Stroke Multidisciplinary Team Training, expertise and continuing education of staff Resources: Administration, Staff Support Education of Secondary Prevention Strategies via Stroke Team Equipment: Technological Infrastructure Process AHA/ASA GWTG for Stroke Patient Management Tool Data collection concurrently reviewed by Quality Assurance RN Measuring national standard benchmarks in secondary stroke care Individualization of care relationship prior to discharge by NP Coordination of care between units and next level of care Analysis quarterly of inpatient stroke data by stroke team Outcome Secondary Prevention Education available to patients prior to discharge Staff collaboration on standards of stroke care Competencies are improved Follow-up with primary stroke patients who have statistically reduced their overall secondary stroke risk and maintaining treatment goals Long term follow up shows decreased incidence of second stroke Figure 1-1 Theoretical Framework Describing Secondary Stroke Prevention

21 21 CHAPTER TWO REVIEW OF THE LITERATURE Introduction The review of the literature will follow Donabedian s model. Structure, process and outcome that support using this framework for this project will be reviewed. The hospital with a dedicated stroke unit has been defined as having clinical expertise of a multidisciplinary team, standard policy for stroke care, administrative support and technological resources. This is evidenced by increased emphasis on quality standards set forth from expert panels from AHA, ASA and the Brain Attack Coalition (Adams, et al, 2007; Alberts, et al., 2005; Schwamm, et al, 2005). Current research on comprehensive stroke unit outcomes, primarily from European studies, has shown reduced rates of stroke morbidity and mortality (Adams, et al., 2007). These European units have skilled neurological professionals, regular collaborative communications, coordinated care and standardized orders to improve best practices for clinical treatment of stroke patients (Adams, et al., 2007). Structure Good structure quality provides consistent treatment by providers, tools, resources and supportive organizational structure (Chin and Muramatsu, 2003). In a consensus statement from the Brain Attack Coalition (BAC), the current comprehensive stroke center requirements were defined based on literature review of clinical trials, metaanalyses, care guidelines, scientific guidelines and other relevant clinical research (Alberts, et al., 2005). Primary and comprehensive stroke centers differ in the level of

22 22 care that can be provided to an acute stroke patient. Certified primary stroke centers (PSC) have the necessary clinical staff, infrastructure and program to treat most stroke patients, but cannot handle complex diagnostic procedures or specialty neurosurgical stroke services. Comprehensive stroke center (CSC) certification is based on a system structure that has 4 key components: 1) Personnel with clinical expertise, 2) specialized diagnostic, surgical and interventional treatments, 3) facility infrastructure and 4) program outreach and education (Alberts, et al., 2005). CSC components were also compiled from a national questionnaire survey from leaders in the field of cerebrovascular disease. Professional personnel for a (CSC) include: 1) Center director who is a board certified, neurosurgeon or neurologist, 2) Staff neurologists and neurosurgeons, 3) interventional and diagnostic radiologists, 4) intensive hospitalists, 5) neuroscience nursing staff, 6) advanced practice nurses, 7) therapists in stroke rehabilitation and 8) case managers and social workers. The nurse practitioner is a key team member involved in stroke patient care, clinical care pathway, research, stroke registry, educational programs, and quality assurance (Alberts, et al., 2005). In a first ever quantitative study of Donabedian s structure, process, outcome model, Kunkel, Rosenqvist, and Westerling (2007) surveyed 386 hospital department heads in Sweden. Quality structure, process and outcome analysis was made to determine components of quality, relationship of the components and the implications of the relationships. Data was analyzed using exploratory factor analysis, confirmatory factor analysis and structural equation modeling. The survey was piloted for reliability and validity of results. Results strongly indicated a significant relationship between structure

23 23 characteristics; defined as quality improvement competence with documented routines, task responsibilities, available colleague support, administrative support, and clear policy and procedure with process and outcome. Kunkel, Rosenqvist, and Westerling (2007) concluded that the better the quality improvement within the structure, the more interrelationship of peer, collegial support within the process and this was translated to a higher outcome. It was also theorized from their data that adequate resources and administrative support, may play an important role in system quality improvement. In a two year, prospective, observational study of 11 VA medical centers, Hoenig and colleagues (2002) gathered data on 288 post acute stroke patients. Their hypotheses questions were: 1) how do system structure, staff expertise and technological infrastructure relate to process of care in stroke patients? And 2) if process is adjusted, is structure related to different stroke outcomes? Subjects were excluded if they did not get sub-acute care. Those included in the study (n=167) were followed 6 months post stroke care using the Functional Independent Measure motor subscale (FIM). Structure statistical variables were classified in 1 of 3 domains: 1) systematic organization, 2) staff expertise, and 3) technological sophistication. Structure was measured by a numeric rating scale in each area according to: 1) a VA rehabilitation bed unit vs. a post acute setting with a protocol for stroke care in place on a common ward, 2) expertise of the staff and diversity of provider types, 3) presence of a clinical nurse specialist, 4) presence of a medical rehabilitation director, 5) amount of continuing education received by specialty rehabilitation providers in stroke care 0-4 times a year and 6) technological infrastructure. The results showed a significant association between all 3 domains of

24 24 structure that were examined. Unadjusted analyses of patient FIM outcomes at 6 months demonstrated a relationship in systemic organization, staff expertise and process of care. There was a direct relationship demonstrated between low organizational structure and staff expertise with poorer outcomes and higher organizational structure and staff expertise with higher FIM scores (Hoenig, et al, 2002). Process Process quality is the set of activities that occur between the provider and the patient; it can include the measurement of care provided, the improvements necessary to perform that care or information provided to empower patients to make their care decisions (Chin and Muramatsu, 2003). In this section, a description of what is known from the research about determining risk factors in TIA or stroke patients and the guidelines necessary for treatment. This information is important in the process of treating these patients and preventing second stroke. Determining Risk Factors for Stroke There are non-modifiable risk factors that create some of the individual risk for primary and secondary TIA and stroke. These risk factors include age, gender, race/ethnicity, low birth weight, and genetic predisposition (Goldstein, et al., 2006). Well supported by the research, modifiable factors that place persons at higher risk for stroke are TIA or ischemic stroke, hypertension, cardiovascular disease; including atherosclerosis, heart failure, peripheral arterial disease, valvular disease, atrial fibrillation, carotid artery stenosis, as well as diabetes, hyperlipidemia, smoking or breathing second hand smoke, poor diet, lack of

25 25 physical activity, obesity, body fat distribution, sickle cell disease and post-menopausal hormone therapy (Goldstein, et al., 2006). Evaluation through a personal history with the patient can provide the necessary factors that can be incorporated in an individualized treatment plan. Guidelines for Prevention of Secondary Stroke The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure that is based on current publication of studies, recommends a thiazide diuretic with an ACEI and a combination of two or more lifestyle modifications to enhance antihypertensive drug efficacy and decrease average stroke risk by 35-40%. These lifestyle modifications include weight reduction, a cardiovascular diet with sodium reduction, physical activity, smoking cessation and moderation of alcohol use (National Heart, Lung and Blood Institute [NHLBI], 2003; Sacco, et al., 2006). National trends as of from the National Health and Nutrition Examination Survey showed that only a third of the persons who are diagnosed with hypertension were adequately controlled (NHLBI, 2003). The Perindopril Protection against Recurrent Stroke Study (PROGRESS) randomized 6,105 patients with stroke or TIA for ACEI alone or ACEI and a diuretic combination therapy. The combination therapy showed a 43% risk reduction for recurrent stroke and the ACEI alone showed no significant benefit (Sacco, et al, 2006). Diabetic Type I and II patients appear to benefit the most from primary prevention of stroke risk (Sacco, et al., 2006). Secondary prevention in these patients is also multifactorial and includes closer monitoring of target goals for a Hemoglobin A1c less than or at 7%, blood pressure at or less than 130/80, and LDL-C at or <70 mg/dl to reduce overall cardiovascular and cerebrovascular risk. Epidemiological studies of diabetic

26 26 patients have shown that a continual reduction in blood pressure between 120/80 to 140/80 can reduce the relative risk of stroke by 44% (Sacco, et al., 2006). This was best accomplished by behavioral counseling, the use of a lipid lowering statin agent and a antiplatelet drug as appropriate, as well as a angiotensin converting enzyme inhibitor (ACEI) or a angiotensin receptor blocker (ARB) for blood pressure control. These hypertension medicines are also recommended by the American Diabetes Association and JNC-7 recommends a thiazide diuretic combined with the ACEI or ARB which reduces the microvascular disease of the kidneys, retinas and peripheral nervous system (NHLBI, 2003; Sacco, et al., 2006) The National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults (NCEP-III) is recommended for comprehensive management of lipids in persons who experienced a stroke or TIA. Statin agents are recommended in all patients with stroke and TIA, cardiovascular heart disease, elevated cholesterol or atherosclerotic origin for their stroke for a target LDL-C <100mg/dl. Lowering LDL cholesterol reduces stroke and cardiovascular morbidity and mortality (Sacco, et al., 2006). Based on the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial, we know that patients with no coronary artery disease who have had a stroke or TIA that go on 80 mg of atorvastatin, a HMG-CoA reductase inhibitor, will significantly reduce their stroke risk and cardiovascular events (Amarenco, et al, 2006).

27 27 Long term anticoagulant therapy with warfarin is recommended for all patients with atrial fibrillation, structural heart disease, prosthetic valve, previous embolic events and over the age of 55. This patient population needs adjusted dosing to keep their target International Normalized Ratio (INR) range of for the best reduction of recurrent stroke. Younger patients or older patients who cannot tolerate warfarin can use enteric coated aspirin 325 mg per day. Patients with a stroke from a myocardial infarction or ischemic coronary artery disease should be on 162 mg of aspirin per day as well as warfarin therapy (Sacco, et al., 2006). Antiplatelet therapy should be used in all patients with stroke or TIA. Currently the recommended dose of aspirin is between mg per day alone or combined with extended release dipyridamole or clopidrogel 75 mg/day alone are all safe for initiation of therapy to decrease secondary stroke. Clopidrogel is recommended for patients who cannot tolerate aspirin therapy and is not recommended to be used with aspirin therapy (Verro, Gorelick & Nguyen, 2008). All of these are acceptable options for the beginning use of antiplatelet medication for discharge from the hospital. Recommendations for healthy lifestyle modifications must be individual specific and open to cultural concerns so they are successful. Blood pressure control rates are poorest in Hispanic Americans and Native Americans (NHLBI, 2003). African Americans are the most affected by heart disease and stroke in the United States and they are usually not controlled on one hypertensive medication (US Department of Health and Human Services, 2003). These patient populations need diuretic and antihypertensive

28 28 medications in combination to provide adequate control initially, with frequent follow up to ensure adequate control, monitoring and education of lifestyle factors. Recommendations for this type of medication management, dietary and lifestyle guideline factors require a clinician or nurse practitioner to follow through with all stroke or TIA patients for patient education and adherence prior to discharge (Alberts, et al., 2005). Outcome Outcome is the change in the patient s current health status related to healthcare decisions by the provider. In this section, current research will be presented from studies examining the outcomes of quality measurements for stroke and TIA that has reduced their risk for second stroke. This research is still beginning to analyze best practice outcomes for secondary stroke risk. Hackam & Spence (2007) performed a meta-analysis of strategies in secondary stroke care by performing a review of 106 randomized control trials of secondary prevention strategies. They found the five most common risk reducing strategies among these studies were comprehensive dietary modification, exercise, aspirin, HMG-CoA Reductase inhibitor (Statin), and antihypertensive medication therapy. Using the Life Long after Cerebral Ischemia (LILAC) study population of over 210,000 patients, a longitudinal, 5 year relative risk reduction was calculated for recurrent vascular events in patients with a TIA or stroke. In those who implemented these strategies, risk was reduced by 80% and TIA patients had a significantly lower 10 year vascular event rate of 35.8%. Results from this study showed that with intensified management of the strategies in addition to aspirin-dipyridamole, intensive blood pressure

29 29 lowering and high dose statins provided a 90% risk reduction and a risk reduction of 94% when done in combination with a carotid endarterectomy. In conclusion, they found that by combining 3 medications with dietary modifications and exercise, recurrent cardiovascular events were reduced by 1out of 5 hospitalized patients with cerebrovascular disease (Hackam & Spence, 2007). These large meta-analyses were conducted to examine outcomes when organized system structure is in place. AHA/ASA s Council on Stroke statement publication for healthcare professionals, Guidelines for Prevention of Stroke in Patients with Ischemic Stroke or Transient Ischemic Attack provided the framework for the current use of secondary stroke treatment guidelines used in this project. These guidelines included an evaluation of atherosclerotic disease risk factors, lifestyle assessment, body mass index, lipid screening and guidelines for statin, hypertensive, and antiplatelet medication use and protective antithrombotic administration (Sacco, et al., 2006). Use of these guidelines to monitor stroke specific care was initiated at the hospital level by the Joint Commission in 2004 by setting quality of care measures for stroke inpatient care. The guidelines require documentation of evidenced based care, along with evaluation of risk and providing multidisciplinary team care (Joint Commission, 2004). In 2000, a pilot for The Get with the Guidelines for cardiovascular disease (GWTG CAD ) Patient Management Tool was started. This is an internet-based, data entry tool developed from the AHA and ASA s secondary prevention performance measures and the Joint Commission s core measures, the first collaborative interactive data base for the GWTG CAD tracks clinical based care of inpatients (LaBresh, et al., 2003). The GWTG CAD

30 30 benchmarks for measuring care have improved secondary cardiovascular practices in one year follow up for the GWTG CAD pilot hospital groups. LaBresh and colleagues used a collaborative learning model that included interactive learning sessions, electronic webcasts to facilitate multidisciplinary teams in a variety of settings, the tools with which to implement change for guideline use between hospital staff in 24 hospitals. This was followed with risk measurement of 1,738 patients admitted for coronary artery disease during July 2000-June Data was obtained on lipid lowering treatment, aspirin use, other antithrombotics, beta-blockers, ACEI s, risk factor management, lifestyle changes, diabetes care, hypertension care, physical activity, smoking cessation and weight management. Based on the data obtained at follow-up at months with these patients, there was significant improvement from baseline in smoking cessation counseling, lipid measurement and treatment, aspirin, and improving blood pressure treatment medications at discharge (LaBresh, et al., 2004). There is a necessity to demonstrate that standard use of secondary stroke based guidelines in the hospital can further reduce ischemic cardiovascular disease, stroke risk and improve quality of life outcomes for primary stroke or TIA patients (LaBresh, et al., 2004). This research is still in its infancy and there is little documented evidence about patient outcomes that are significant for secondary stroke care education in the literature. During a one year, investigative study, the GWTG SM for stroke was used to assess quality adherence in 99 volunteer community and teaching hospitals throughout the U.S. The study included 18,410 patients hospitalized for stroke and TIA (LaBresh, et al, 2008). Data was collected using the GWTG SM for stroke, during a pre-intervention

31 31 baseline period of three months. After this baseline period from April 2003 to March 2004; data was collected at quarterly intervals covering acute care and secondary prevention measures with hospital staff training and support. (Table 2-1 GWTG SM Stroke Quality Measures). Using the collaborative learning model, 7 pre-specified core performance measures were used in an all or none provision for eligibility of patients to be in the study. These included: 1) early thrombolytic medications presenting within the first two hours of symptom onset, 2) antithrombotics medications administered within the first 48 hours of admission, 3) deep vein thrombosis (DVT) prophylaxis, 4) antithrombotics at discharge, 5) anticoagulation at discharge for patients with atrial fibrillation, 6) lipid treatment for LDL-C > 100 mg/dl, and 7) smoking cessation counseling (LaBresh, et al, 2008). Eligible patients for the all or none measure were defined as the percentage of patients that received all of the seven performance measures. There were significant gradual increases from baseline in all individual secondary prevention measures. This was the first large study of its kind to show quality improvement of stroke patients in the hospital for secondary stroke protective measures. Other collaborative hospital studies have been smaller and have looked at other quality care measures for acute care (LaBresh, et al., 2008). The study population for this project differed from the LaBresh et al, (2008) study in that it included the use of hypertensive medication at discharge as a performance measure.

32 32 Table 2-1 GWTG Stroke Quality Measures (DC) Discharge DC Antithrombotics Definitions for Eligible* Patients for Antithrombotic therapy prescribed at discharge. Anti-hypertensive medication at DC Atrial fibrillation (AF) Smoking LDL Cholesterol (LDL-C) LDL 100 Lipid Rx Weight Management Diabetes Management Patients who have a hypertensive agent at discharge. Anticoagulation therapy for patients with AF that are documented during the hospitalization. Cessation intervention (appropriate medication and /or counseling) provided at discharge. A LDL-C measured in the hospital as the highest first 48 hours after admission, non-fasting is okay. If available, a fasting sample within the last 3 months prior to admission in the outpatient record. Lipid lowering agent for LDL>100 prescribed at discharge or documentation that patient was taking a lipid lowering agent on admission. Statin agent prescribed at discharge for all patients except those patients with untreated levels of LDL<100 mg/dl. Recommendations at discharge for reducing weight for those patients with Body Mass Index (BMI) at 25 or greater. (Calculated as weight in kilograms divided by the height in meters 2 ). Patients who have diabetes or are taking oral hypoglycemics prior to admission that are discharged while receiving diabetic medication (oral hypoglycemic agents or insulin). *Eligible patients are those without any medical contraindications e.g. treatment intolerance, excessive risk or adverse reaction, patient refusal, terminal illness, and comfort care only are documented as reasons for non-treatment for each of the applicable measures. Discharge measures exclude patients who die, are discharged to hospice care or other short term general hospital, leave against medical advice or whom a discharge destination is undocumented or undeterminable. (LaBresh, Reeves, Frankel, Albright, Schwamm, 2008).

33 33 Summary Treatment of care options for stroke or TIA must be timely and aggressive to reduce future stroke risk. There has been current research that has demonstrated value for acute care stroke patients to be treated using a multifactorial treatment plan prior to discharge to avoid a gap in care. Translating the individual risk for patients is the bedside clinician or NP s goal in developing a treatment plan for secondary stroke care in these patients. The GWTG SM Patient Management Tool provides the structure for hospitals to monitor quality measures and implement changes to improve secondary stroke quality of care.

34 34 CHAPTER THREE PROJECT IN DETAIL Introduction This chapter will describe the procedures used to accomplish the project aims. Aim 1 is to describe the stroke structure of care within the hospital, in an urban southwest hospital. Aim 2 will be to describe the process of care by analysis of GWTG SM Patient Management Tool data performance measures for secondary stroke care on 30 TIA and stroke inpatients. Then, Aim 3 will be to discuss steps for implementing a secondary stroke plan for patients prior to their discharge. Procedures The first aim of this project is to describe an urban Tucson, AZ community hospital system for acute stroke care. The author was involved in the initial phases of neuroscience administrative meetings. Information was obtained through attending these meetings, conducting interviews with hospital staff, viewing the hospital website and discussion with the medical director in determination of current hospital structure with respect to staff and neuroscience pathway for stroke care. Aim 2 was to describe the data from the Get with the Guidelines (GWTG SM ) Patient Management Tool that is related to the prevention of second stroke. GWTG SM is managed by a secure internet data management company called Outcome Sciences, Inc (LaBresh, et al., 2008). The hospital uses the GWTG SM as a quality assurance tool. As part of the quality assurance process, the quality R.N. case manager entered the GWTG SM chart data retrospectively in January 2007 for the last quarter; October through December A random computer sample was used to identify 30 cases of ischemic stroke or TIA, based on the International Classification of

35 35 Diseases, Ninth Revision (ICD-9) diagnosis codes. There are no identifiers in the GWTG SM Outcome Sciences (2007) database. The author obtained permission to use the 30 patients data from the hospital s administrative staff and stroke neuroscience medical director. GWTG SM data was accessed via Outcome Sciences Inc. (2007) password protected website. Cases within the GWTG SM database Patient management tool are identified only by number. In order for the author to become familiar with the database, the author and the quality assurance RN attended a GWTG SM for stroke teleconference over the internet for an hour and a half on data entry technique. Each case was entered through a series of screens that ask information about the performance indicator questions to be answered with a drop down answer. This information determines how each case will be included or excluded in that particular field s numerator of data. All cases were summarized for each performance indicator related to second stroke risk. The GWTG SM tool reflects performance indicators related to all areas of acute stroke care; including those related to risk for second stroke. There were seven performance indicators for this project, 1) management of lipids prior to discharge, 2) antithrombotic and or 3) anticoagulant use and 4) antihypertensive medications prescribed for discharge, 5) body mass index (BMI) calculations and lifestyle modification, 6) smoking cessation counseling and 7) diabetic medications prior to discharge. Analysis of GWTG dataset was performed according to the recommendations of GWTG, AHA/ASA. Patient cases were excluded if there was insufficient chart documentation to validate for certainty whether that measure was performed. They were excluded if the patient expired, was transferred to another hospital, or left against medical advice or if there was a contraindication for not meeting the performance standard. The numerator is the subset of patients who meet the criteria that the measure is analyzing. The denominator of patients is the total number of patients that are eligible to be analyzed. Using numerator and denominator

36 36 values, the data is expressed as the percent compliance for a given performance measure. The core set of seven descriptors for performance measures are based on evidence and clinical trials. In most pilot studies of this process; a patient was excluded from analysis if all seven descriptors were not addressed (by documentation) for an eligible patient s care (LaBresh, et al., 2008). However for this project, the author specifically wanted to know if the performance indicators related to secondary stroke risk was performed. Therefore, the author used all 30 cases. Those cases with documentation related to performance indicators of secondary stroke risk was the numerator, and the denominator included all patients that would have been eligible for that performance measure. Based on the information obtained from Aims 1 and 2, examination of the hospital structure for this project and the GWTG SM data on performance measures were analyzed to obtain the information necessary to describe an implementation plan for the prevention of secondary stroke in hospitalized patients prior to discharge. Results The first aim of this project was to describe the hospital system for stroke care in an urban Tucson, AZ community hospital. This project takes place in a 309 bed sub-acute bed and acute care urban hospital with 440 active and provisional physicians and 1700 employees. The hospital is in the process of obtaining their stroke center certification. The units responsible for the care of these patients are spread throughout the hospital including the emergency room, intensive care, telemetry and medical surgical units. Members of the acute stroke team include a medical director who is a neurologist, neurosurgeon, hospitalist internal medicine physicians, staff neurologist(s), vascular specialists, therapists, nurse managers and nursing staff that provide direct clinical care. A quality assurance RN case manager was the data entry staff person and

37 37 described to the author how she used the GWTG SM template data collection for each case. Stroke patients are triaged based on level of need and bed availability by house supervising nurse, floor nurse managers and attending hospitalist physician. The hospital has regular continuing education yearly for hospital staff according to their specific area of primary assignment within the hospital. Over the last two years, there has been skills offered for training on neurological assessment based on the National Institute of Health Stroke Scale (NIHSS), charting and protocols have been presented for hospital staff in anticipation of a designated primary stroke center certification by the Joint Commission. At the time of this study, there were a number of stroke protocols in the process of being formalized in all areas of the hospital. The emergency unit had a standing order sheet in place for rapid assessment and initiation of orders and tests for possible administration of intravenous thrombolytic (t-pa). Laboratory services were working on a more stream line process for the emergency room to receive lab results on stroke patients within 45 minutes. A neurologist is available for consult within 45 minutes of a call from the ER to see a patient 24 hours per day. A neurosurgeon, neurointerventionalist and neuroradiologist are on staff and available when it is deemed necessary. There were no standard secondary stroke treatment protocols in place at the time of this project. The hospital has done a primary stroke check fair and a cardiovascular outreach education session for the community twice yearly. The purpose of aim 2 was to describe the data from the Get with the Guidelines (GWTG SM ) Patient Management Tool that is related to the prevention of second stroke. As shown in Figure 3-1, the demographics of the patient population consisted of 30 patients between the ages of with a mean age of 75 years of age. There were 16 females and 14 males; 25 were Caucasian, 3 Hispanic patients and 2 African Americans. With respect to final disposition after discharge, 14 were discharged to home and 14 were discharged to a sub-acute facility. There was one death prior to discharge and 1 transfer to an inpatient hospice unit. With respect to stroke type, there

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012 Faculty Prevention Sharon Ewer, RN, BSN, CNRN Stroke Program Coordinator Baptist Health Montgomery, Alabama Satellite Conference and Live Webcast Monday, May 21, 2012 2:00 4:00 p.m. Central Time Produced

More information

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Guidelines Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Stroke/TIA Nearly 700,000 ischemic strokes and 240,000 TIAs every year in the United States Currently, the risk for

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

Stroke/VTE Quality Measure Build for Meaningful Use Stage 1

Stroke/VTE Quality Measure Build for Meaningful Use Stage 1 Stroke/VTE Quality Measure Build for Meaningful Use Stage 1 Presented by Susan Haviland, BSN RN Senior Consult, Santa Rosa Consulting Meaningful Use Quality Measures Centers for Medicare and Medicaid Services

More information

Stroke Care First week

Stroke Care First week Stroke Care First week Florence Nightingale (1820 1910) Stroke Unit Dedicated personnel trained in stroke management Stepwise guidelines supported by explicit checklists Continuous monitoring available

More information

2013 ACO Quality Measures

2013 ACO Quality Measures ACO 1-7 Patient Satisfaction Survey Consumer Assessment of HealthCare Providers Survey (CAHPS) 1. Getting Timely Care, Appointments, Information 2. How well Your Providers Communicate 3. Patient Rating

More information

Department of Veterans Affairs VHA DIRECTIVE 2011-038 Veterans Health Administration Washington, DC 20420 November 2, 2011

Department of Veterans Affairs VHA DIRECTIVE 2011-038 Veterans Health Administration Washington, DC 20420 November 2, 2011 Department of Veterans Affairs VHA DIRECTIVE 2011-038 Veterans Health Administration Washington, DC 20420 TREATMENT OF ACUTE ISCHEMIC STROKE (AIS) 1. PURPOSE: This Veterans Health Administration (VHA)

More information

Atrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE

Atrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE Atrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE Clinical practice guidelines serve as an educational reference, and do not supersede the clinical judgment of the treating physician with

More information

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis Methodology: 8 respondents The measures are incorporated into one of four sections: Highly

More information

Level III Stroke Center Data Collection Requirements

Level III Stroke Center Data Collection Requirements Who? Level III Stroke Center Data Collection Requirements All LERN Level III Stroke Centers. LERN Level I and II Stroke Centers have reporting requirements to The Joint Commission or other Board approved

More information

Evidence-Based Secondary Stroke Prevention and Adherence to Guidelines

Evidence-Based Secondary Stroke Prevention and Adherence to Guidelines Evidence-Based Secondary Stroke Prevention and Adherence to Guidelines Mitchell S.V. Elkind, MD, MS Associate Professor of Neurology Columbia University New York, NY Presenter Disclosure Information Mitchell

More information

STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND:

STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND: STROKE PREVENTION IN ATRIAL FIBRILLATION TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention

More information

Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology

Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology The chart below lists the measures (and specialty exclusions) that eligible providers must demonstrate

More information

Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Summary. http://www.cms.gov/ehrincentiveprograms/

Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Summary. http://www.cms.gov/ehrincentiveprograms/ Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Summary 2010 What are the Requirements of Stage 1 Meaningful Use? Basic Overview of Stage 1 Meaningful Use: Reporting period

More information

ALBERTA PROVINCIAL STROKE STRATEGY (APSS)

ALBERTA PROVINCIAL STROKE STRATEGY (APSS) ALBERTA PROVINCIAL STROKE STRATEGY (APSS) Stroke Systems of Care Key Components APSS Pillar Recommendations March 28, 2007 1 The following is a summary of the key components and APSS Pillar recommendations

More information

AHA/ASA Ischemic Stroke Performance Measures

AHA/ASA Ischemic Stroke Performance Measures AHA/ASA Ischemic Stroke Performance Measures 1. Venous thromboembolism prophylaxis Percentage of patients with ischemic stroke who receive venous thromboembolism prophylaxis Numerator Hospital day 0 or

More information

New Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013

New Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013 New Treatments for Stroke Prevention in Atrial Fibrillation John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013 Classification Paroxysmal atrial fibrillation (AF) Last < 7

More information

STROKE PREVENTION IN ATRIAL FIBRILLATION

STROKE PREVENTION IN ATRIAL FIBRILLATION STROKE PREVENTION IN ATRIAL FIBRILLATION OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention of ischemic stroke and arterial thromboembolism in patients

More information

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological

More information

Radiology Business Management Association Technology Task Force. Sample Request for Proposal

Radiology Business Management Association Technology Task Force. Sample Request for Proposal Technology Task Force Sample Request for Proposal This document has been created by the RBMA s Technology Task Force as a guideline for use by RBMA members working with potential suppliers of Electronic

More information

KIH Cardiac Rehabilitation Program

KIH Cardiac Rehabilitation Program KIH Cardiac Rehabilitation Program For any further information Contact: +92-51-2870361-3, 2271154 Feedback@kih.com.pk What is Cardiac Rehabilitation Cardiac rehabilitation describes all measures used to

More information

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,

More information

Stage 1 Meaningful Use for Specialists. NYC REACH Primary Care Information Project NYC Department of Health & Mental Hygiene

Stage 1 Meaningful Use for Specialists. NYC REACH Primary Care Information Project NYC Department of Health & Mental Hygiene Stage 1 Meaningful Use for Specialists NYC REACH Primary Care Information Project NYC Department of Health & Mental Hygiene 1 Today s Agenda Meaningful Use Overview Meaningful Use Measures Resources Primary

More information

CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014

CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014 CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014 e 55 0495 2 Emergency Department (ED)- 1 Emergency Department Throughput Median time from

More information

HealthCare Partners of Nevada. Heart Failure

HealthCare Partners of Nevada. Heart Failure HealthCare Partners of Nevada Heart Failure Disease Management Program 2010 HF DISEASE MANAGEMENT PROGRAM The HealthCare Partners of Nevada (HCPNV) offers a Disease Management program for members with

More information

CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications

CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications CHAPTER V DISCUSSION Background Diabetes mellitus is a chronic condition but people with diabetes can lead a normal life provided they keep their diabetes under control. Life style modifications (LSM)

More information

Main Effect of Screening for Coronary Artery Disease Using CT

Main Effect of Screening for Coronary Artery Disease Using CT Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,

More information

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach. Inpatient Anticoagulation Safety Purpose: Policy: To provide safe and effective anticoagulation therapy through a collaborative approach. Upon the written order of a physician, Heparin, Low Molecular Weight

More information

Rx Updates New Guidelines, New Medications What You Need to Know

Rx Updates New Guidelines, New Medications What You Need to Know Rx Updates New Guidelines, New Medications What You Need to Know Maria Pruchnicki, PharmD, BCPS, BCACP, CLS Associate Professor of Clinical Pharmacy OSU College of Pharmacy Background scope and impact

More information

Clinical Audit in Hospital Authority. Dr Betty Young Convenor for Clinical Audit, Hospital Authority

Clinical Audit in Hospital Authority. Dr Betty Young Convenor for Clinical Audit, Hospital Authority Clinical Audit in Hospital Authority Dr Betty Young Convenor for Clinical Audit, Hospital Authority Background 1990 1992 1996 1998 2005 Establishment of the Hospital Authority Quality Assurance Subcommittee

More information

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below Name: generic (trade) Rivaroxaban (Xarelto ) HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below What it is Indications

More information

The International Agenda for Stroke

The International Agenda for Stroke 1st Global Conference on Healthy Lifestyles and Noncommunicable Diseases Control Moscow, 28-29 April, 2011 The International Agenda for Stroke Marc Fisher MD, University of Massachusetts Editor-in-Chief,

More information

Mar. 31, 2011 (202) 690-6145. Improving Quality of Care for Medicare Patients: Accountable Care Organizations

Mar. 31, 2011 (202) 690-6145. Improving Quality of Care for Medicare Patients: Accountable Care Organizations DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services Room 352-G 200 Independence Avenue, SW Washington, DC 20201 Office of Media Affairs MEDICARE FACT SHEET FOR IMMEDIATE RELEASE

More information

convey the clinical quality measure's title, number, owner/developer and contact

convey the clinical quality measure's title, number, owner/developer and contact CMS-0033-P 153 convey the clinical quality measure's title, number, owner/developer and contact information, and a link to existing electronic specifications where applicable. TABLE 20: Proposed Clinical

More information

Patient and Hospital Characteristics Associated with Assessment For Rehabilitation During Hospitalization for Acute Stroke

Patient and Hospital Characteristics Associated with Assessment For Rehabilitation During Hospitalization for Acute Stroke Patient and Hospital Characteristics Associated with Assessment For Rehabilitation During Hospitalization for Acute Stroke Lead Author: Janet Prvu Bettger, ScD, FAHA Duke University ; janet.bettger@duke.edu

More information

Approved: Acute Stroke Ready Hospital Advanced Certification Program

Approved: Acute Stroke Ready Hospital Advanced Certification Program Approved: Acute Stroke Ready Hospital Advanced Certification Program The Joint Commission recently developed a new Disease- Specific Care Advanced Certification program for Acute Stroke Ready Hospitals

More information

Hypertension Best Practices Symposium

Hypertension Best Practices Symposium essentia health: east region 1 Hypertension Best Practices Symposium RN Hypertension Management Pilot Essentia Health: East Region Duluth, MN ORGANIZATION PROFILE Essentia Health is an integrated health

More information

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG

More information

Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW

Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW Clinical Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW NQF 0105 PQRS 9 NQF 0002 PQRS 66 Antidepressant Medication Management Appropriate Testing for Children with Pharyngitis (2-18 years)

More information

Guidelines for the management of hypertension in patients with diabetes mellitus

Guidelines for the management of hypertension in patients with diabetes mellitus Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes

More information

Chapter 3: Review of Literature Stroke

Chapter 3: Review of Literature Stroke Chapter 3: Review of Literature Stroke INTRODUCTION Cerebrovascular accident (also known as stroke) is a serious health problem in the United States and a leading cause of long-term disability. In this

More information

Your Time on the Island The Role of the Stroke Coordinator

Your Time on the Island The Role of the Stroke Coordinator Your Time on the Island The Role of the Stroke Coordinator Andrea Jaeger, MHA, BSN, CNRN Original Presentation by: Alex Graves, MS, ANP 1 Presenter Disclosure Information Andrea Jaeger, MHA, BSN, CNRN

More information

Psychiatrists and Reporting on Meaningful Use Stage 1. August 6, 2012

Psychiatrists and Reporting on Meaningful Use Stage 1. August 6, 2012 Psychiatrists and Reporting on Meaningful Use Stage 1 August 6, 2012 Quick Overview Functional Measures Providers (tracked by NPI) must report on 15 core objectives and associated measures and 5 objectives

More information

Hospital-Based Sub-Acute Stroke Care and Secondary Prevention. Timothy Lukovits,, M.D.

Hospital-Based Sub-Acute Stroke Care and Secondary Prevention. Timothy Lukovits,, M.D. Hospital-Based Sub-Acute Stroke Care and Secondary Prevention Timothy Lukovits,, M.D. Volunteer group members Shalini Bansil,, MD Summit NJ Ji Chong,, MD, NYC, NY Srinath Kadimi,, M.D. Fairfield, CT Steve

More information

Making Sense of the New Statin guidelines. They are more than just lowering your cholesterol!

Making Sense of the New Statin guidelines. They are more than just lowering your cholesterol! Making Sense of the New Statin guidelines They are more than just lowering your cholesterol! No Disclosures Margaret (Peg) O Donnell DNPs, FNP, ANP B-C, FAANP Senior Nurse Practitioner South Nassau Communities

More information

9/5/14. Objectives. Atrial Fibrillation (AF)

9/5/14. Objectives. Atrial Fibrillation (AF) Novel Anticoagulation for Prevention of Stroke in Patients with Atrial Fibrillation Objectives 1. Review current evidence on use of warfarin in individuals with atrial fibrillation 2. Compare the three

More information

ACUTE STROKE PATHWAY

ACUTE STROKE PATHWAY ACUTE STROKE PATHWAY THERE IS A NEED FOR STATEWIDE STROKE SYSTEM OF CARE ALL MISSISSIPPIANS SHOULD BE ABLE TO ACCESS NEW PROTOCOLS FOR STROKE TREATMENT JOINT EFFORT WITH EMS, PHYSICIANS, HOSPITALS AND

More information

Chapter Three Accountable Care Organizations

Chapter Three Accountable Care Organizations Chapter Three Accountable Care Organizations One of the most talked-about changes in health care delivery in recent decades is Accountable Care Organizations, or ACOs. Having gained the attention of both

More information

Baskets of Care Diabetes Subcommittee

Baskets of Care Diabetes Subcommittee Baskets of Care Diabetes Subcommittee Disclaimer: This background information is not intended to be a comprehensive scientific discussion of the topic, but rather an attempt to provide a baseline level

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY Measure #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented National Quality Strategy Domain: Community / Population Health 2016 PQRS OPTIONS F INDIVIDUAL MEASURES:

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY Measure #326 (NQF 1525): Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS,

More information

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media News Release Not intended for U.S. and UK Media Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer Forms Collaboration with Academic and Governmental Institutions for Rivaroxaban

More information

Service Specification Template Department of Health, updated June 2015

Service Specification Template Department of Health, updated June 2015 Service Specification Template Department of Health, updated June 2015 Service Specification No. : 2 Service: Commissioner Lead: Provider Lead: Period: Anti-coagulation monitoring Date of Review: 31 st

More information

How To Treat Dyslipidemia

How To Treat Dyslipidemia An International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia Introduction Executive Summary The International Atherosclerosis Society (IAS) here updates

More information

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Athersclerotic Risk

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Athersclerotic Risk 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Athersclerotic Risk Lynne T Braun, PhD, CNP, FAHA, FAAN Professor of Nursing, Nurse Practitioner Rush University Medical Center 2

More information

Cardiac Rehabilitation at AUBMC

Cardiac Rehabilitation at AUBMC Cardiac Rehabilitation at AUBMC Clinical Protocols and The Role of The Advanced Practice Nurse Presentation by: Mohamad Issa, MSN, BSN, BC- RN, AUBMC CCU OUTLINE Background on cardiovascular diseases History

More information

Evaluating ED Patients with Transient Ischemic Attack: Inpatient vs. Outpatient Strategies

Evaluating ED Patients with Transient Ischemic Attack: Inpatient vs. Outpatient Strategies Evaluating ED Patients with Transient Ischemic Attack: Inpatient vs. Outpatient Strategies Michael A. Ross MD FACEP Associate Professor of Emergency Medicine Wayne State University School of Medicine Detroit

More information

AVAILABILITY AND ACCESSIBILITY OF CARDIAC REHABILITATION SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES QUESTIONNAIRE

AVAILABILITY AND ACCESSIBILITY OF CARDIAC REHABILITATION SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES QUESTIONNAIRE AVAILABILITY AND ACCESSIBILITY OF CARDIAC REHABILITATION SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES QUESTIONNAIRE To be completed by Staff Cardiologists at an adult cardiac institute/department. INSTRUCTIONS:

More information

American Stroke Association Highlights Carla D. English, MHS, MHSA

American Stroke Association Highlights Carla D. English, MHS, MHSA AMERICAN STROKE ASSOCIATION HIGHLIGHTS 1 CARLA D. ENGLISH, MHS, MHSA QUALITY & SYSTEMS IMPROVEMENT GREATER SOUTHEAST AFFILIATE ASA VISION: Empower people to live longer, healthier lives free of stroke

More information

The author has no disclosures

The author has no disclosures Mary Bradbury, PharmD, BCPS Clinical Pharmacy Specialist, Cardiac Surgery September 18, 2012 Mary.bradbury@inova.org This presentation will discuss unlabeled and investigational use of products The author

More information

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation PATIENT EDUCATION GUIDE What is atrial fibrillation? Atrial fibrillation

More information

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY Care Pathway Triage category ATRIAL FIBRILLATION PATHWAY ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY AF/ FLUTTER IS PRIMARY REASON FOR PRESENTATION YES NO ONSET SYMPTOMS OF AF./../ TIME DURATION OF AF

More information

JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates. January 30, 2014

JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates. January 30, 2014 JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates January 30, 2014 GOALS Review key recommendations from recently published guidelines on blood pressure and cholesterol management Discuss

More information

Coventry Health Care of Florida, Inc. Coventry Health Plan of Florida, Inc. Coventry Health and Life Insurance Company Commercial Lines of Business

Coventry Health Care of Florida, Inc. Coventry Health Plan of Florida, Inc. Coventry Health and Life Insurance Company Commercial Lines of Business Coventry Health Care of Florida, Inc. Coventry Health Plan of Florida, Inc. Coventry Health and Life Insurance Company Commercial Lines of Business Quality Management Program 2012 Overview Quality Improvement

More information

PHYSICIAN ORDERS TRANSIENT ISCHEMIC ATTACK (TIA) OBSERVATION

PHYSICIAN ORDERS TRANSIENT ISCHEMIC ATTACK (TIA) OBSERVATION SCREENING- ABCD-2 Score The ABCD2 score is a risk assessment tool designed to improve the prediction of short-term stroke risk after a transient ischemic attack (TIA). Higher ABCD2 scores are associated

More information

NICE TA 275: Apixaban for the prevention of stroke and systemic embolism in people with non-valvular atrial fibrillation

NICE TA 275: Apixaban for the prevention of stroke and systemic embolism in people with non-valvular atrial fibrillation Service Notification in response to DHSSPS endorsed NICE Technology Appraisals NICE TA 275: Apixaban for the prevention of stroke and systemic embolism in people with non-valvular atrial fibrillation 1

More information

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process

More information

OBJECTIVES AGING POPULATION AGING POPULATION AGING IMPACT ON MEDICARE AGING POPULATION

OBJECTIVES AGING POPULATION AGING POPULATION AGING IMPACT ON MEDICARE AGING POPULATION OBJECTIVES Kimberly S. Hodge, PhDc, MSN, RN, ACNS-BC, CCRN- K Director, ACO Care Management & Clinical Nurse Specialist Franciscan ACO, Inc. Central Indiana Region Indianapolis, IN By the end of this session

More information

Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness

Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness Barriers to Healthcare Services for People with Mental Disorders Cardiovascular disorders and diabetes in people with severe mental illness Dr. med. J. Cordes LVR- Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität

More information

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38 Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac

More information

AMERICAN BURN ASSOCIATION BURN CENTER VERIFICATION REVIEW PROGRAM Verificatoin Criterea EFFECTIVE JANUARY 1, 2015. Criterion. Level (1 or 2) Number

AMERICAN BURN ASSOCIATION BURN CENTER VERIFICATION REVIEW PROGRAM Verificatoin Criterea EFFECTIVE JANUARY 1, 2015. Criterion. Level (1 or 2) Number Criterion AMERICAN BURN ASSOCIATION BURN CENTER VERIFICATION REVIEW PROGRAM Criterion Level (1 or 2) Number Criterion BURN CENTER ADMINISTRATION 1. The burn center hospital is currently accredited by The

More information

Medical Management of Ischemic Stroke: An Update. Siddharth Sehgal, MD Medical Director, TMH Neuroscience Center

Medical Management of Ischemic Stroke: An Update. Siddharth Sehgal, MD Medical Director, TMH Neuroscience Center Medical Management of Ischemic Stroke: An Update Siddharth Sehgal, MD Medical Director, TMH Neuroscience Center Objectives Diagnostic evaluation and management of acute ischemic stroke. Inpatient management

More information

HITECH Act Update: An Overview of the Medicare and Medicaid EHR Incentive Programs Regulations

HITECH Act Update: An Overview of the Medicare and Medicaid EHR Incentive Programs Regulations HITECH Act Update: An Overview of the Medicare and Medicaid EHR Incentive Programs Regulations The Health Information Technology for Economic and Clinical Health Act (HITECH Act) was enacted as part of

More information

CERTIFICATE OF NEED AND ACUTE CARE LICENSURE PROGRAM. Hospital Licensing Standards: Emergency Department and Trauma Services:

CERTIFICATE OF NEED AND ACUTE CARE LICENSURE PROGRAM. Hospital Licensing Standards: Emergency Department and Trauma Services: HEALTH AND SENIOR SERVICES HEALTH CARE QUALITY AND OVERSIGHT BRANCH HEALTH CARE QUALITY AND OVERSIGHT DIVISION ACUTE CARE FACILITY OVERSIGHT CERTIFICATE OF NEED AND ACUTE CARE LICENSURE PROGRAM Hospital

More information

Let s talk about: Stroke

Let s talk about: Stroke Let s talk about: Stroke February 20 th 2013 Laura Wilson Christine Stables Questions 1. Why is knowing about stroke important? 2. What exactly is a stroke and what are the symptoms? 3. What should I do

More information

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better Marian Taylor, M.D. Medical University of South Carolina Director, Cardiac Rehabilitation I have no disclosures.

More information

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG MED Hospitalist Stroke-TIA Vital Signs Vital Signs Q4H (DEF)* Q2H Q1H Vital Signs Orthostatic Activity Activity Bedrest, for 12 hours then Up ad lib (DEF)* Bedrest, for 24 hours then Up ad lib Up Ad Lib

More information

3/2/2010 Post CABG R h e bili a i tat on Ahmed Elkerdany Professor o f oof C ardiac Cardiac Surgery Ain Shams University 1

3/2/2010 Post CABG R h e bili a i tat on Ahmed Elkerdany Professor o f oof C ardiac Cardiac Surgery Ain Shams University 1 Post CABG Rehabilitation i Ahmed Elkerdany Professor of Cardiac Surgery Ain Shams University 1 Definition Cardiac rehabilitation services are comprehensive, long-term programs involving : medical evaluation.

More information

Meaningful Use: Registration, Attestation, Workflow Tips and Tricks

Meaningful Use: Registration, Attestation, Workflow Tips and Tricks Meaningful Use: Registration, Attestation, Workflow Tips and Tricks Allison L. Weathers, MD Medical Director, Information Services Rush University Medical Center Gregory J. Esper, MD, MBA Vice Chair, Neurology

More information

Vascular Risk Reduction: Addressing Vascular Risk

Vascular Risk Reduction: Addressing Vascular Risk Vascular Risk Reduction: Addressing Vascular Risk Vascular Risk Reduction (VRR) Welcome! Presentation & Activities Focus: Managing known risk factors for vascular disease. Engage, collaborate and have

More information

Diabetes and Heart Disease

Diabetes and Heart Disease Diabetes and Heart Disease Diabetes and Heart Disease According to the American Heart Association, diabetes is one of the six major risk factors of cardiovascular disease. Affecting more than 7% of the

More information

S1. Which of the following age categories do you fall into? Please select one answer only. 18-44 years of age. 45-64 years of age. 65-74 years of age

S1. Which of the following age categories do you fall into? Please select one answer only. 18-44 years of age. 45-64 years of age. 65-74 years of age Supplemental Materials Supplemental Methods Patient Survey We are presently conducting a market research study to help us better understand some of the challenges experienced by patients taking anticoagulants

More information

CASE SELECTION: EVALUATING THE RECORDS TO DETERMINE WHICH CASES TO REJECT OR TAKE

CASE SELECTION: EVALUATING THE RECORDS TO DETERMINE WHICH CASES TO REJECT OR TAKE CASE SELECTION: EVALUATING THE RECORDS TO DETERMINE WHICH CASES TO REJECT OR TAKE Philip C. Henry, Esquire Henry, Spiegel, Fried & Milling, LLP Suite 2450 950 East Paces Ferry Road Atlanta, Georgia 30326

More information

Listen to your heart: Good Cardiovascular Health for Life

Listen to your heart: Good Cardiovascular Health for Life Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular

More information

Nurse Practitioners (NPs) and Physician Assistants (PAs): What s the Difference?

Nurse Practitioners (NPs) and Physician Assistants (PAs): What s the Difference? Nurse Practitioners (NPs) and Physician Assistants (PAs): What s the Difference? More than ever before, patients receive medical care from a variety of practitioners, including physicians, physician assistants

More information

Antiplatelet and Antithrombotic Therapy. Dr Curry Grant Stroke Prevention Clinic Quinte Health Care

Antiplatelet and Antithrombotic Therapy. Dr Curry Grant Stroke Prevention Clinic Quinte Health Care Antiplatelet and Antithrombotic Therapy Dr Curry Grant Stroke Prevention Clinic Quinte Health Care Disclosure of Potential for Conflict of Interest Dr. F.C. Grant Atrial Fibrillation FINANCIAL DISCLOSURE:

More information

Coronary Heart Disease (CHD) Brief

Coronary Heart Disease (CHD) Brief Coronary Heart Disease (CHD) Brief What is Coronary Heart Disease? Coronary Heart Disease (CHD), also called coronary artery disease 1, is the most common heart condition in the United States. It occurs

More information

Population Health Management Program

Population Health Management Program Population Health Management Program Program (formerly Disease Management) is dedicated to improving our members health and quality of life. Our Population Health Management Programs aim to improve care

More information

105 CMR 143.000: STANDARDS GOVERNING CARDIAC REHABILITATION TREATMENT

105 CMR 143.000: STANDARDS GOVERNING CARDIAC REHABILITATION TREATMENT 105 CMR 143.000: STANDARDS GOVERNING CARDIAC REHABILITATION TREATMENT Section 143.001: Purpose and Scope 143.002: Authority 143.003: Citation 143.004: Definitions 143.005: General Requirements for Cardiac

More information

ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease

ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease Diabetes, prediabetes and cardiovascular disease Classes of recommendations Levels of evidence Recommended treatment targets for patients with diabetes and CAD Definition, classification and screening

More information

High Blood Cholesterol

High Blood Cholesterol National Cholesterol Education Program ATP III Guidelines At-A-Glance Quick Desk Reference 1 Step 1 2 Step 2 3 Step 3 Determine lipoprotein levels obtain complete lipoprotein profile after 9- to 12-hour

More information

BRIEFING PAPER STROKE SERVICES REDESIGN

BRIEFING PAPER STROKE SERVICES REDESIGN 1. Introduction BRIEFING PAPER STROKE SERVICES REDESIGN Agenda Item 3 Stroke is the leading cause of adult disability in Wales, and the third most common cause of death, after cancer and heart disease.

More information

ACCOUNTABLE CARE ORGANIZATION QUICK-REFERENCE SETUP GUIDE

ACCOUNTABLE CARE ORGANIZATION QUICK-REFERENCE SETUP GUIDE ACCOUNTABLE CARE ORGANIZATION QUICK-REFERENCE SETUP GUIDE V 9.0 eclinicalworks, 2013. All rights reserved Contents CONTENTS ACO SETUP 3 Demographics 3 ACO 12 4 ACO 13 6 ACO 14 7 ACO 15 8 ACO 16 9 ACO 17

More information

High Desert Medical Group Connections for Life Program Description

High Desert Medical Group Connections for Life Program Description High Desert Medical Group Connections for Life Program Description POLICY: High Desert Medical Group ("HDMG") promotes patient health and wellbeing by actively coordinating services for members with multiple

More information

Cardiovascular Risk in Diabetes

Cardiovascular Risk in Diabetes Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,

More information

Physician and other health professional services

Physician and other health professional services O n l i n e A p p e n d i x e s 4 Physician and other health professional services 4-A O n l i n e A p p e n d i x Access to physician and other health professional services 4 a1 Access to physician care

More information

Anticoagulants in Atrial Fibrillation

Anticoagulants in Atrial Fibrillation Anticoagulants in Atrial Fibrillation Starting and Stopping Them Safely Carmine D Amico, D.O. Overview Learning objectives Introduction Basic concepts Treatment strategy & options Summary 1 Learning objectives

More information

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1

More information

CLINICAL GUIDELINE FOR SECONDARY PREVENTION AFTER STROKE OR TIA (PRIMARY AND SECONDARY CARE CORNWALL) MANAGEMENT 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR SECONDARY PREVENTION AFTER STROKE OR TIA (PRIMARY AND SECONDARY CARE CORNWALL) MANAGEMENT 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR SECONDARY PREVENTION AFTER STROKE OR TIA (PRIMARY AND SECONDARY CARE CORNWALL) MANAGEMENT 1. Aim/Purpose of this Guideline The aim of this document to inform clinicians on management

More information

Type 1 Diabetes ( Juvenile Diabetes)

Type 1 Diabetes ( Juvenile Diabetes) Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.

More information